US clears first enzyme therapy for PKU

25th May 2018 Uncategorised 0

Biomarin’s Palynziq has been approved as the first enzyme therapy to treat the rare brain-threatening genetic disease phenylketonuria (PKU) in adults in the US.

More: US clears first enzyme therapy for PKU
Source: News